Anti-IL-13 antibodies, human

Anti-IL-13 antibodies, human

Clone: REA1011 | Dilution: 1:50
Clone REA1011 recognizes the interleukin-13 (IL-13), which is produced primarily by activated Tʜ2 cells, but also by mast cells, natural killer (NK) cells, and dendritic cells (DCs). IL-13 exerts anti-inflammatory effects on monocytes and macrophages. Furthermore, it inhibits the expression of pro-inflammatory cytokines, such as IL-1β, TNF-α, IL-6, and IL-8. IL-13 has also been shown to enhance B cell proliferation and to induce isotype switching, resulting in an increased production of IgE. IL-13, in contrast to IL-4, fails to induce Tʜ2 cell differentiation, one of the hallmarks of the allergic response.
Additional Information: Clone REA1011 displays negligible binding to Fc receptors.

Alternative Names


Technical specifications

  • Antigen: IL-13
  • Clone: REA1011
  • Isotype: recombinant human IgG1
  • Isotype control: REA Control (I) antibodies
  • Alternative names of antigen: Interleukin-13
  • Entrez Gene ID: 3596
  • Molecular mass of antigen [kDa]: 13
  • Cross-reactivity:
    rhesus monkey (
    Macaca mulatta
  • Distribution of antigen: dendritic cells, mast cells, NK cells, T cells
  • Product format: Reagents are supplied in buffer containing stabilizer and 0.05% sodium azide.
  • Fixation: The antibody is suited for staining of formaldehyde-fixed cells.
  • Storage: Store protected from light at 2–8 °C. Do not freeze.
  • Available conjugates: FITC, PE, APC, PE-Vio615, Vio667
Product options: -

Product information

Order no.